MAPK/ERK pathway

MAPK/ERK pathway
Name	MAPK/ERK pathway
Organism	Eukaryota
Components	RAF family; MEK1/2; ERK1/2
Function	signal transduction; cell proliferation; differentiation

MAPK/ERK pathway The MAPK/ERK pathway is a conserved eukaryotic signal transduction cascade that conveys extracellular stimuli to intracellular responses, mediating proliferation, differentiation, and survival; it was delineated through landmark studies involving growth factors and oncogenes in model systems such as HeLa cells, Xenopus laevis, and Saccharomyces cerevisiae. Key discoveries were shaped by investigators associated with institutions like the Cold Spring Harbor Laboratory, Harvard University, and the Max Planck Society, and have influenced therapeutic strategies developed by organizations such as Genentech and Roche.

Overview

The pathway operates as a three-tiered kinase module characterized historically by work at Massachusetts Institute of Technology, Stanford University, and University of Cambridge, linking receptor activation at the plasma membrane to nuclear effectors studied in contexts including the Nobel Prize-recognized research tradition. It integrates signals from receptor tyrosine kinases exemplified by the Epidermal Growth Factor Receptor, G-protein-coupled receptors such as β-adrenergic receptor, and integrins characterized in experiments at Johns Hopkins University, routing information through conserved kinases studied in laboratories at Institut Pasteur and University of California, San Francisco.

Components and Mechanism

The cascade typically begins with ligand binding to receptors like Epidermal Growth Factor receptors and involves adaptor proteins such as Grb2 and guanine nucleotide exchange factors typified by SOS1, which activate small GTPases including RAS proteins (e.g., KRAS, NRAS, HRAS). Activated RAS recruits and activates RAF family kinases—ARAF, BRAF, and CRAF (RAF1)—which phosphorylate and activate dual-specificity kinases MAP2K1/MAP2K2 (commonly called MEK1/2); MEK in turn phosphorylates extracellular signal-regulated kinases ERK1/ERK2 (encoded by MAPK3 and MAPK1), which translocate to the nucleus to phosphorylate transcription factors such as ELK1, c-Fos, and c-Myc. Structural and biochemical insights have been advanced by research groups at European Molecular Biology Laboratory, Biotechnology and Biological Sciences Research Council, and the Howard Hughes Medical Institute.

Regulation and Feedback

Regulatory control occurs via scaffold proteins like KSR1 and IQGAP1, phosphatases such as DUSP6 and PP2A, and upstream modulators including receptor endocytosis mechanisms explored at University of Oxford and Yale University. Negative feedback loops involve ERK-mediated phosphorylation of SOS and RAF components, while positive feedback can be mediated by transcriptional induction of growth factors studied in laboratories at University of Chicago and Columbia University. Crosstalk with pathways characterized by investigators at European Research Council centers—such as the PI3K-AKT pathway, JAK-STAT pathway, and Wnt signaling pathway—modulates output, and dysregulation is influenced by mutations cataloged in resources maintained by National Institutes of Health and clinical consortia like The Cancer Genome Atlas.

Biological Functions and Physiological Roles

ERK signaling controls cell cycle progression through regulators identified at Cold Spring Harbor Laboratory and Dana-Farber Cancer Institute, including effects on cyclin D1 and retinoblastoma protein studied in experiments at University of Pennsylvania. During development, ERK activity patterns govern fate decisions in systems from Drosophila melanogaster embryogenesis analyzed at Max Planck Institute for Developmental Biology to vertebrate morphogenesis investigated at Salk Institute and Karolinska Institute. Neuronal plasticity roles have been elucidated in studies at MIT and University College London, where ERK-dependent transcription influences long-term potentiation and memory consolidation involving factors like CREB. Metabolic and stress responses mediated by ERK signaling have been explored by teams at The Rockefeller University and Imperial College London.

Involvement in Disease and Cancer

Oncogenic activation through mutations in genes such as BRAF V600E and KRAS G12D has been implicated in malignancies characterized at clinical centers including Memorial Sloan Kettering Cancer Center, Mayo Clinic, and MD Anderson Cancer Center, with tumor types spanning melanoma, colorectal carcinoma, and lung adenocarcinoma documented by consortia like National Cancer Institute and European Society for Medical Oncology. Therapeutic targeting of pathway components has produced drugs developed by companies including GlaxoSmithKline, AstraZeneca, and Novartis; examples include RAF inhibitors and MEK inhibitors whose clinical trials were conducted at institutions such as University of Texas MD Anderson Cancer Center and Stanford Health Care. Resistance mechanisms involving feedback reactivation and parallel pathway upregulation have been reported in studies from Broad Institute, Fred Hutchinson Cancer Research Center, and collaborative networks like COGENT.

Experimental Methods and Detection

Biochemical assays and imaging approaches used to study the cascade include phospho-specific immunoblotting and immunohistochemistry protocols standardized at Addenbrooke's Hospital and Mayo Clinic, mass spectrometry workflows developed at Lawrence Berkeley National Laboratory, and live-cell reporters implemented by groups at ETH Zurich and California Institute of Technology. Genetic perturbation techniques such as CRISPR screens pioneered at Broad Institute and RNA interference described at Whitehead Institute enable functional dissection, while single-cell transcriptomics and proteomics platforms from EMBL-EBI and Wellcome Trust Sanger Institute provide systems-level resolution. Structural characterization of kinases has been contributed by researchers at RCSB Protein Data Bank depositors and crystallography centers like Diamond Light Source.

Category:Signal transduction